Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Mayne KJ., Sardell RJ., Staplin N., Judge PK., Zhu D., Sammons E., Cherney DZI., Cheung AK., Maggioni AP., Nangaku M., Rossello X., Tuttle KR., Ihara K., Iwata T., Wanner C., Emberson J., Preiss D., Landray MJ., Baigent C., Haynes R., Herrington WG., on behalf of the EMPA-KIDNEY Collaborative Group None.

DOI

10.2215/CJN.0000000000000498

Type

Journal article

Journal

Clin J Am Soc Nephrol

Publication Date

01/09/2024

Volume

19

Pages

1119 - 1129

Permalink Original publication